2m 2m 2m 2m 2m 2m 2m
Cytodyn (CYDY)
OTC
$0.21+$0.004 (+1.94%)
Price as of Aug 21, 2026- $287.6MMarket Cap
- -29.29%1-Year Change
- BiotechnologyIndustry
Cytodyn (CYDY)
$0.21+$0.004 (+1.94%)
CYDY | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.21 | ||
Change | +$0.004 (+1.94%) | ||
Open | $0.21 | ||
High | $0.21 | ||
Low | $0.20 | ||
Previous Close | $0.21 | ||
Volume | 803,743 | ||
30-Day Average Volume | 1,459,797 | ||
1-Week Change | 10.73% | ||
1-Month Change | 3.45% | ||
1-Year Change | -29.29% | ||
3-Year Change | 0.00% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 1.4B | ||
Total Assets | $18.5M | ||
Market Cap | $287.6M | ||
Enterprise Value | $326.4M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$4.7M | ||
Free Cash Flow | -$5.5M | ||
EBIT | -$4.7M | ||
EBITDA | -$4.7M | ||
Net Working Capital | -$32.0M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -70 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -3 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -52 | ||
Price/Operating Cash Flow | -52 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||